AEVEX has done almost everything a young defense contractor is supposed to do since going public. It raised guidance twice, swelled its pipeline and announced a sizable maritime acquisition. Yet the stock has lost nearly half its value since the last report, falling 46.6% while the S&P 500 slipped just 2.9%. That disconnect frames the November 11 release, due after the close. The market appears to be pricing in a painful transition as the company's largest program winds down, and this quarter is the first real look at how steep that cliff is.

The Street is braced for a smaller quarter. Consensus calls for revenue of $150.8 million, down roughly 25% from the $201.8 million posted in the second quarter, and earnings of $0.09 per share versus $0.07 last time. That decline is not a surprise. Management told investors that the UCOM Deep Strike program, which drove the bulk of first-half sales, rolls off in the back half of 2026. It also said accelerated material receipts had pulled revenue forward, leaving second-half revenue below the first half. With roughly $418.5 million booked through June, the raised full-year target of $700 million to $720 million implies about $282 million to $302 million for the final two quarters. The Q3 consensus fits comfortably within that math. The more telling detail is the EPS estimate, which asks for higher per-share profit on materially lower sales. That puts margin execution and cost discipline under a brighter light than the top line.

The first thing to check is whether management holds or lifts the $700 million to $720 million revenue range and the $105 million to $111.5 million adjusted EBITDA outlook. After two consecutive raises, a simple reaffirmation would be defensible given the Deep Strike runoff. Any trim, however, would cut against the confident tone of the last call. Backlog coverage was about 95% of the full-year midpoint, so a shortfall would point to execution or timing problems rather than missing demand.

Orders deserve equal scrutiny. Trailing book-to-bill eased to 1.08 from 1.16, and management acknowledged that some awards were taking longer because of the Middle East conflict, changes in acquisition processes and shifting priorities. It also expects fiscal 2027 to open under a continuing resolution. The company's mix is weighted toward short-cycle orders, which leaves less long-range visibility. So progress in converting the roughly $10.5 billion pipeline into signed contracts is the best evidence that something can replace Deep Strike. Reinforcing that case would take a book-to-bill back above 1.0, concrete new tactical systems awards and payoff from the select-prime recognition. A further slide would feed the bear case.

Then there is Black Sea Technologies, the up-to-$650 million deal targeted to close in September. Investors need confirmation that HSR and other closing conditions were cleared on schedule. They also need early detail on integration and on the more than $110 million in funded backlog it brings. Management described the deal as near-term accretive. Notably, the roughly 12.7 million shares in the equity consideration were valued at $27.50, well above today's $11.53 price, which sharpens attention on dilution.

Sentiment has swung from mildly bullish heading into last quarter to firmly bearish now. The stock trades far below its 200-day moving average of $19.87 and sits closer to the $9.64 low of its post-earnings range than the $23.62 high. That suggests a skeptical bar, though skepticism alone does not guarantee a relief rally. The central question is whether AEVEX can show that new awards, added capacity and the maritime business are arriving fast enough to bridge the Deep Strike gap. Clear evidence of that would keep the growth narrative intact.